Company intelligence / Profile preview
Zentiva
Prague, Prague, Czech Republicorpha.net ↗
- Ownership
- Private
- Employees
- ~4800
- Development stage
- Commercial
01
Overview
Zentiva is a leading European pharmaceutical company specializing in high-quality affordable generic medicines. It has expanded rapidly since becoming independent in 2018 under Advent International’s backing. The company produces a wide range of dosage forms including solids, injectables, eye drops, ointments as well as APIs. It serves over one hundred million people primarily across Europe with an expanding footprint beyond[1][2][3][6].
- Therapeutic areas
- PulmonologyCardiovascularEndocrinologyOtherOncologyNeurology
- Modalities
- Small molecule genericsInjectable solutionsEye dropsSterile ointmentsHormonesActive Pharmaceutical Ingredients (APIs) and intermediates
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
No specific major pharma/biotech partnerships disclosed publicly; collaborates broadly with suppliers and external manufacturing partners for supply security[3].
Beyond the preview
Go deeper on Zentiva.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zentiva.